Net Income

European biotech leader Hifas da Terra launches in the US, aiming to disrupt the mushroom supplement industry with its unique focus on clinical trials.

Following a historic $2B revenue year, Tradeweb's CEO will address institutional investors, focusing on AI, digital assets, and global market expansion.

Kitchen equipment maker Li Bang International is acquiring a major caterer, a bold move to nearly double its revenue and dive into China's booming food service market.

With U.S. cancer centers tripling adoption of its targeted drug delivery device, RenovoRx signals a potential shift in treating solid tumors.

A $2.5B private project gets the green light to build a subsea cable, promising to end Puerto Rico's blackouts and forge a new era of Caribbean energy.

Quanta System is ditching distributors for a direct US operation in North Carolina, aiming to shake up the competitive surgical and urology laser market.

Trump Media plans a complex deal to spin off Truth Social after its fusion energy merger, aiming to create two distinct publicly traded companies.

Antelope Enterprise Holdings just bought $1M in Bitcoin, launching its 'Genius Plan.' But with falling revenue, is this a bold new chapter or a risky bet?

As CLPS prepares to release H1 FY2026 results, investors are watching for sustained recovery and the impact of its global diversification strategy.

Fintech giant Green Dot is skipping its Q4 earnings call, signaling a massive strategic shift as it splits its bank and tech operations in a billion-dollar deal.

Metacon's major Greek hydrogen project hits a key milestone with a €2.6M payment, signaling strong progress in Southern Europe's energy transition.

A staggering loss at JinkoSolar's key subsidiary reveals a brutal price war and oversupply crisis rocking the global solar manufacturing sector.

IoT specialist KORE Group agrees to a take-private acquisition by Searchlight and Abry, offering a massive 691% premium to shareholders.

Sustainable energy provider ThomasLloyd is merging with a SPAC to go public, aiming to solve the massive power crisis facing the booming AI industry.

Despite a dip in annual profits, Boralex commissions major UK and Canadian projects, showcasing financial resilience and commitment to its 2030 growth plan.

The natural gas producer raised its quarterly dividend by 11%, backed by strong earnings and a positive outlook despite volatile energy prices.

The organ transplant innovator's massive Q4 profit came from a tax rule, but it signals a major turning point and confidence in long-term profitability.

As Summit Midstream sets its Q4 earnings date, all eyes are on whether recent acquisitions and strong gas trends can solidify its financial recovery.

Fulgent Genetics reports revenue growth but faces a pivotal year with a major customer loss, betting its future on strategic acquisitions and a promising drug pipeline.

MedX Health Corp. lands a crucial $2.7M in initial funding, aiming for $5M to expand its skin-screening tech into occupational health and manage debt.